FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012531860> ?p ?o ?g. }

• W2012531860 endingPage "433" @default.
• W2012531860 startingPage "427" @default.
• W2012531860 abstract "Decreased circulating levels of adiponectin, a novel adipose-derived adipocytokine, in obesity possibly contribute to the development of insulin resistance which is a major factor in the pathogenesis of type 2 diabetes. The present study was conducted to examine whether circulating and adipose tissue adiponectin levels are modulated by chronic treatment with metformin and intensive treatment with insulin in murine models of obesity and type 2 diabetes, db/db mice with a C57BL/KsJ genetic background. Nine-week-old male db/db mice were treated with metformin, insulin, and vehicle for 4 weeks. Expectedly, metformin treatment led to inhibition of weight gain and improvement of hyperinsulinemia. Insulin treatment lowered fasting blood glucose levels to normal values, although it sustained hyperinsulinemic state. However, after 4 weeks of treatment, serum adiponectin levels were not significantly elevated in either metformin-treated or insulin-treated db/db mouse group (14.2 ± 0.7 and 16.7 ± 1.0 μg/ml, respectively) compared to vehicle-treated group (14.9 ± 0.6 μg/ml). Similarly, adipose tissue adiponectin levels determined by Western blot analysis were not increased in either metformin-treated or insulin-treated group relative to vehicle-treated group. Recent studies have shown that adiponectin possibly has the same physiological effects on lipid and glucose metabolism that metformin has. Therefore, an elevation in blood concentration of metformin following the treatment might lead to suppression in adiponectin synthesis in adipose tissue, independent of inhibition in weight gain and improvement in hyperinsulinemia by metformin treatment. The present results indicate that adiponectin is not involved in the mechanism by which metformin treatment enhances insulin sensitivity. Moreover, our results suggest that adiponectin synthesis in adipose tissue may be suppressed under hyperinsulinemic state sustained by insulin treatment, even though hyperglycemia is markedly reduced. We conclude that antidiabetic treatment with metformin and insulin does not affect circulating and adipose tissue adiponectin levels." @default.
• W2012531860 created "2016-06-24" @default.
• W2012531860 creator A5016507641 @default.
• W2012531860 creator A5041218978 @default.
• W2012531860 creator A5044499778 @default.
• W2012531860 creator A5055016294 @default.
• W2012531860 creator A5060279300 @default.
• W2012531860 creator A5066952889 @default.
• W2012531860 creator A5067240699 @default.
• W2012531860 creator A5075630675 @default.
• W2012531860 creator A5075793122 @default.
• W2012531860 creator A5084429509 @default.
• W2012531860 date "2005-01-01" @default.
• W2012531860 modified "2023-09-27" @default.
• W2012531860 title "Effects of Antidiabetic Treatment with Metformin and Insulin on Serum and Adipose Tissue Adiponectin Levels in db/db Mice" @default.
• W2012531860 cites W1524321743 @default.
• W2012531860 cites W1577992062 @default.
• W2012531860 cites W1587875569 @default.
• W2012531860 cites W1981261500 @default.
• W2012531860 cites W1986721386 @default.
• W2012531860 cites W1996713062 @default.
• W2012531860 cites W2001727439 @default.
• W2012531860 cites W2009818179 @default.
• W2012531860 cites W2013838480 @default.
• W2012531860 cites W2020949125 @default.
• W2012531860 cites W2024891055 @default.
• W2012531860 cites W2056347227 @default.
• W2012531860 cites W2060899732 @default.
• W2012531860 cites W2065697164 @default.
• W2012531860 cites W2091759162 @default.
• W2012531860 cites W2095763488 @default.
• W2012531860 cites W2097794068 @default.
• W2012531860 cites W2108931588 @default.
• W2012531860 cites W2120688902 @default.
• W2012531860 cites W2131702141 @default.
• W2012531860 cites W2142504521 @default.
• W2012531860 cites W2165391345 @default.
• W2012531860 cites W2315982688 @default.
• W2012531860 cites W4235391466 @default.
• W2012531860 cites W4239191207 @default.
• W2012531860 cites W4242152781 @default.
• W2012531860 cites W4243857162 @default.
• W2012531860 cites W4244571387 @default.
• W2012531860 cites W4256514001 @default.
• W2012531860 doi "https://doi.org/10.1507/endocrj.52.427" @default.
• W2012531860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16127210" @default.
• W2012531860 hasPublicationYear "2005" @default.
• W2012531860 type Work @default.
• W2012531860 sameAs 2012531860 @default.
• W2012531860 citedByCount "54" @default.
• W2012531860 countsByYear W20125318602012 @default.
• W2012531860 countsByYear W20125318602013 @default.
• W2012531860 countsByYear W20125318602014 @default.
• W2012531860 countsByYear W20125318602015 @default.
• W2012531860 countsByYear W20125318602016 @default.
• W2012531860 countsByYear W20125318602017 @default.
• W2012531860 countsByYear W20125318602018 @default.
• W2012531860 countsByYear W20125318602019 @default.
• W2012531860 countsByYear W20125318602020 @default.
• W2012531860 countsByYear W20125318602021 @default.
• W2012531860 countsByYear W20125318602022 @default.
• W2012531860 countsByYear W20125318602023 @default.
• W2012531860 crossrefType "journal-article" @default.
• W2012531860 hasAuthorship W2012531860A5016507641 @default.
• W2012531860 hasAuthorship W2012531860A5041218978 @default.
• W2012531860 hasAuthorship W2012531860A5044499778 @default.
• W2012531860 hasAuthorship W2012531860A5055016294 @default.
• W2012531860 hasAuthorship W2012531860A5060279300 @default.
• W2012531860 hasAuthorship W2012531860A5066952889 @default.
• W2012531860 hasAuthorship W2012531860A5067240699 @default.
• W2012531860 hasAuthorship W2012531860A5075630675 @default.
• W2012531860 hasAuthorship W2012531860A5075793122 @default.
• W2012531860 hasAuthorship W2012531860A5084429509 @default.
• W2012531860 hasBestOaLocation W20125318601 @default.
• W2012531860 hasConcept C126322002 @default.
• W2012531860 hasConcept C134018914 @default.
• W2012531860 hasConcept C171089720 @default.
• W2012531860 hasConcept C2776782570 @default.
• W2012531860 hasConcept C2777180221 @default.
• W2012531860 hasConcept C2777391703 @default.
• W2012531860 hasConcept C2779306644 @default.
• W2012531860 hasConcept C2780323712 @default.
• W2012531860 hasConcept C2780988686 @default.
• W2012531860 hasConcept C555293320 @default.
• W2012531860 hasConcept C71924100 @default.
• W2012531860 hasConceptScore W2012531860C126322002 @default.
• W2012531860 hasConceptScore W2012531860C134018914 @default.
• W2012531860 hasConceptScore W2012531860C171089720 @default.
• W2012531860 hasConceptScore W2012531860C2776782570 @default.
• W2012531860 hasConceptScore W2012531860C2777180221 @default.
• W2012531860 hasConceptScore W2012531860C2777391703 @default.
• W2012531860 hasConceptScore W2012531860C2779306644 @default.
• W2012531860 hasConceptScore W2012531860C2780323712 @default.
• W2012531860 hasConceptScore W2012531860C2780988686 @default.
• W2012531860 hasConceptScore W2012531860C555293320 @default.
• W2012531860 hasConceptScore W2012531860C71924100 @default.
• W2012531860 hasIssue "4" @default.
• W2012531860 hasLocation W20125318601 @default.

• next